← Leaderboards
Kavita M Babu
Univ Of Massachusetts Med Sch Worcester
$1,281,725
Attributed
$2,056,257
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $811.7K · FY2018–23$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,056,257 · 2
By mechanism
UG3$1,549,064 · 1
R21$507,193 · 1
Top collaborators
- Roland C Merchant3 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Edward W Boyer$8,919,066
Others in their field
Other Emerging Leaders on “Participant”
- Chanza Baytop · Westat, Inc.$271,217,917
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Beth Baseler · Leidos Biomedical Research, Inc.$117,364,154
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$102,389,765
- Scott Topper · Broad Institute, Inc.$101,052,360
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
Research focus
ParticipantOpioid OverdoseFentanylResponseAccident And Emergency DepartmentOpioidPharmaceutical PreparationsNaloxoneEmergency Department PatientUrineOverdoseSamplingSurveysSiteTest ResultPrevalenceAdultHeroinProtocols DocumentationClinical PracticeCarfentanilDrug TestingPatient Self-ReportDrug Usage
Grant awards (5)
Sentanyl II: A Multi-State Analysis of Fentanyl/Analogs, Naloxone, and Clinical Features of Non-Fatal Opioid Overdose$692,346
UG3 · FY2023 · DA
Sentanyl II: A Multi-State Analysis of Fentanyl/Analogs, Naloxone, and Clinical Features of Non-Fatal Opioid Overdose$119,343
UG3 · FY2023 · DA
Sentanyl II: A Multi-State Analysis of Fentanyl/Analogs, Naloxone, and Clinical Features of Non-Fatal Opioid Overdose$737,375
UG3 · FY2022 · DA
Sentanyl: Emergency Department-Based Surveillance for Clandestine Opioids$265,269
R21 · FY2019 · DA · contact PI
Sentanyl: Emergency Department-Based Surveillance for Clandestine Opioids$241,924
R21 · FY2018 · DA · contact PI